Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
Pharmaceutical Statistics|September 3, 2016
Simulation-based sample-sizing and power calculations in logistic regression with partial prior informationAndrew P Grieve, Shah-Jalal SarkerPharmaceutical Statistics|February 23, 2021
Optimising the trade-off between type I and II error rates in the Bayesian contextRosalind J Walley, Andrew P GrieveNature Reviews. Drug Discovery|July 13, 2026
Design, simulate, refine: simulation-guided clinical trials for accelerated drug developmentElias Laurin Meyer, Tim Friede, Andrew P Grieve, et al.Biometrical Journal. Biometrische Zeitschrift|March 23, 2016
The predictive distribution of the residual variability in the linear-fixed effects model for clinical cross-over trialsAnja Bertsche, Gerhard Nehmiz, Jan Beyersmann, et al.Journal of Clinical Epidemiology|December 27, 2011
Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designsJennifer M Nicholas, Andrew P Grieve, Martin C GullifordJournal of Biopharmaceutical Statistics|November 21, 2007
Flexible design and efficient implementation of adaptive dose-finding studiesChristopher J Weir, David J Spiegelhalter, Andrew P GrieveJournal of Psychiatric Practice|July 22, 2011
Phase I trials: from traditional to newer approaches part IIMatthew Macaluso, Michael Krams, Sheldon H PreskornJournal of Psychiatric Practice|May 19, 2011
Phase I trials: from traditional to newer approaches. Part IMatthew Macaluso, Michael Krams, Sheldon H PreskornClinical Trials (London, England)|March 27, 2010
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product developmentJudith Quinlan, Brenda Gaydos, Jeff Maca, et al.Pharmaceutical Statistics|February 17, 2017
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practiceSheila M Bird, Rosemary A Bailey, Andrew P Grieve, et al.Pageof 6